CCP
RMTI icon

Corient Capital Partners’s Rockwell Medical RMTI Stock Holding History

Corient Capital Partners’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-98
Closed -$33K – 473
2019
Q2 		$33K Sell
98
-214
-69% -$109K 0.01% 407
2019
Q1 		$195K Buy
+312
New +$142K 0.03% 327

Other funds holding RMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Corient Capital Partners's RMTI Position: Q3 2019 in Review

Corient Capital Partners sold out of Rockwell Medical (RMTI) in Q3 2019, closing a stake of 98 shares — an estimated $33K sold.

Corient Capital Partners first reported a position in RMTI in Q1 2019 and held it in 2 quarters. The position peaked at $195K in Q1 2019. 90 funds tracked by Wall St. Rank hold RMTI as of Q3 2019.

  • Corient Capital Partners reported no remaining Rockwell Medical position as of Q3 2019 after selling out during the quarter.
  • Corient Capital Partners sold 98 Rockwell Medical shares in Q3 2019, an estimated $33K.
  • Corient Capital Partners first reported a position in Rockwell Medical in Q1 2019 and held it in 2 quarters.
  • Corient Capital Partners's Rockwell Medical position peaked at $195K in Q1 2019.
  • 90 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2019.

Based on Corient Capital Partners's 13F filing for Q3 2019, filed 6 Nov 2019.